Viewing Study NCT01360632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-02-21 @ 10:13 PM
Study NCT ID: NCT01360632
Status: COMPLETED
Last Update Posted: 2016-01-01
First Post: 2011-05-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Depressive Disorder View
None Depression View
None Depressive Disorder, Major View
None Mood Disorders View
None Mental Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None OPC-34712 View
None brexpiprazole View
None Major Depressive Disorder View
None Adjunctive Treatment View